NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
AINMF stock price ended at $0.72 on 火曜日, after rising 2.86%
On the latest trading day Mar 24, 2026, the stock price of AINMF rose by 2.86%, climbing from $0.72 to $0.72. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.72 and a high of $0.72. Notably, trading volume dropped by 70 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 1.0K shares were traded, equating to a market value of approximately $66.1M.